Subject:
- Active Substance: Cefiderocol
- Name: Fetcroja®
- Therapeutic area: Infectious diseases
- Pharmaceutical company: Shionogi GmbH
Time table:
- Publication of final assessment: 16.06.2020
Assessment information:
- Title: Cefiderocol for the treatment of infections due to aerobic Gram-negative bacteria in adult patients with limited treatment options
- Author/Co-Author: AIFA (Italy), NOMA (Norway)
- Dedicated Reviewers: AEMPS (Spain), HAS (France), IQWIG (Germany)